Viewing Study NCT00291967


Ignite Creation Date: 2025-12-25 @ 12:40 AM
Ignite Modification Date: 2026-05-09 @ 3:25 PM
Study NCT ID: NCT00291967
Status: COMPLETED
Last Update Posted: 2006-12-08
First Post: 2006-02-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diphtheria View
None Tetanus View
None Pertussis View
None Hepatitis B View
None Hib Diseases View
None Neisseria Meningitidis Serogroups A & C Diseases View
Keywords: